Lewis Opler, MD, PhD
Professor of Clinical Psychiatry
Adjunct Professor of Psychiatry,
NYU School of Medicine
Special Adjunct Research Professor in the Clinical Psychology Doctoral Program,
Long Island University
Lewis A. Opler, MD, PhD, is an administrator, researcher, educator, and clinician.
He is presently Director of Adult Psychopharmacology Consultation Services for the NYS Office of Mental Health. Dr. Opler is coauthor of the Positive and Negative Syndrome Scale (PANSS) and is on the faculty of Columbia's Center for Prevention of Homelessness (Dr. Carol Caton-Principal Investigator).
Dr. Opler enjoys teaching diverse audiences: faculty, fellows, residents, advocates, and consumers.
In addition to over 200 academic publications, Dr. Opler has published three books for a larger lay audience, aimed at destigmatizing mental illness and drug therapy. He has received numerous awards, including being New York State Psychiatric Association's Harvey Bluestone awardee in 2008 and receiving a National Alliance on Mental Illness Exemplary Psychiatrist Award in 2010.
Dr. Opler has been acknowledged by his peers as among our country's best clinicians, and he is listed in both the Best Doctors in New York City and Best Doctors in America.
Undergraduate: Harvard University, B.A. (magna cum laude), 1965-1969
Medical School: Albert Einstein College of Medicine, M.D., 1969-1976
Doctoral Degree: Albert Einstein College of Medicine, Ph.D. (in Pharmacology), 1969-1975
Residency: Albert Einstein College of Medicine, Resident in Psychiatry, 1976-1979
Board Certifications: American Board of Psychiatry and Neurology (Psychiatry), April 1983
• combining pharmacotherapy and psychotherapy
• treating persons with schizophrenia and other psychotic disorders
Lewis A. Opler, MD, PhD, PC
765 Gramatan Avenue
Mount Vernon, NY 10552
1-Development of the Positive and Negative Syndrome Scale (PANSS), the "gold standard" in assessing symptom severity in schizophrenia and other psychotic disorders
2-Pharmacotherapy of serious mental illness
1. Opler LA, Kay SR, Rosado V, Lindenmayer J-P: Positive and negative syndromes in chronic schizophrenic inpatients. J Nerv Ment Dis 1984;172: 317-325
2. Opler LA, Caton CLM, Shrout P, Dominguez B, Kass FI: Symptom profiles and homessness in schizophrenia. J Nerv Ment Dis 1994;182: 174-178
3. Opler LA, Albert D, Ramirez PM: Psychopharmacological treatment of negative schizophrenic symptoms. Oompr Psychiatry 1994;35: 16-28
4. Opler LA, White L, Caton CLM, Dominguez B, Hirshfield S, Shrout PE: Gender differences in the reslationship of homelessness to symptom severity, substance abuse, and neuroleptic noncompliance in schizophrenia. J Nerv Ment Dis 2001;189: 449-456
5. Opler LA, Opler MG, Arnsten AFT: Ameliorating treatment-refractory depression with intranasal ketamine: potential nmda receptor actions in the pain circuitry representing mental anguish. CNS Spectrums 2015;In press